A phase II Study of weekly irinotecan in patients with metastatic colorectal cancer refractory to 5 FU based chemotherapy

KARAOĞLU A., YALÇIN Ş., Tekuzman G., ERMAN M., ALTUNDAĞ Ö., ÇAKMAK ÖKSÜZOĞLU Ö. B., ...More

ASCO, Thirty-Seventh Annual Meeting, 12 - 15 May 2001

  • Publication Type: Conference Paper / Summary Text
  • Dokuz Eylül University Affiliated: No